Selvaraj Jubie Selected Research

benzimidazolone

1/2020

A New Class of Coumate Benzimidazole Hybrids as BRCA 1 Mimetics Through Unconventional Binding Mode; Synthesis and Preliminary Cytotoxicity Screening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Selvaraj Jubie Research Topics

Disease

5	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2019
3	Neoplasms (Cancer) 01/2021 - 01/2020
1	Diabetes Mellitus 01/2023
1	Dengue (Dengue Fever) 01/2022
1	Japanese Encephalitis 01/2022
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2022
1	Yellow Fever 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 09/2020
1	Disease Progression 09/2020
1	Carcinoma (Carcinomatosis) 03/2013
1	Muscle Weakness 01/2012
1	Demyelinating Diseases (Demyelinating Disease) 01/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
1	LipidsIBA 01/2024
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2024
1	AntioxidantsIBA 01/2023
1	ThioredoxinsIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2022
1	VaccinesIBA 01/2022
1	Mebendazole (Anti-Worm)FDA Link 01/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2021
1	benzimidazoleIBA 01/2021
1	ZincIBA 01/2021
1	3-chloro-4-dimethylaminothioangelicin (CDATA)IBA 01/2021
1	Albendazole (Albenza)FDA Link 01/2021
1	Cyclin DIBA 01/2021
1	AlbuminsIBA 01/2021
1	LigandsIBA 09/2020
1	Staphylococcal Protein A (Protein A)IBA 09/2020
1	Glutamic Acid (Glutamate)FDA Link 09/2020
1	Estrogen Receptor alphaIBA 01/2020
1	4-methylcoumarin 7-O-sulfamateIBA 01/2020
1	benzimidazoloneIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2013
1	Synthetic DrugsIBA 01/2012
1	Ethidium (Ethidium Bromide)IBA 01/2012

Therapy/Procedure

5	Therapeutics 01/2024 - 12/2019